Search Results (89)

Background/Objectives: The Rapid Access Chest Pain Assessment Clinic (RACPAC) streamlines the evaluation of low-to-intermediate risk chest pain and helps avoid unnecessary hospitalisation. Biomarkers {low-density lipoprotein cholesterol (LDL-c) and high-sensitivity C-reactive protein (hsCRP)} are established cardiovascular risk markers. Yet, their diagnostic value for stable coronary artery disease (CAD) in RACPAC remains uncertain. Therefore, we aimed to determine the utility of biomarkers in predicting the presence of CAD in the RACPAC setting. Methods: A retrospective cohort study of consecutive adults attending RACPAC between 2012 and 2021. Multivariable logistic regression and receiver operating characteristic analyses, including prespecified subgroup and sensitivity analyses, were used to evaluate the predictive value of hsCRP and LDL-c for the presence of CAD detected on CT Coronary Angiogram (CTCA) or Treadmill Stress Echocardiography (TSE) as the primary outcome. Results: 3569 patients were included in this study, the mean age was 55.4 ± 11.3 years, and 48.8% were female; 37.4% had hypertension, while 39.5% had dyslipidemia. The mean LDL-c was 3.1 ± 0.9 mmol/L, and the median hsCRP was 1.9 mg/L (IQR 0.9 to 3.8). The regression analysis for the primary outcome showed that neither hsCRP nor LDL-c predicted CAD on CTCA (hsCRP OR 1.00, 95% CI 0.99 to 1.02, p = 0.70; LDL-c OR 1.16, 95% CI 0.97 to 1.39, p = 0.11). On TSE, hsCRP was not associated with CAD, while LDL-c showed an inverse association with CAD (hsCRP OR 0.98, 95% CI 0.83 to 1.00, p = 0.78; LDL-c OR 0.44, 95% CI 0.21 to 0.87, p = 0.02). ROC analysis showed AUC 0.553 for log hsCRP (95% CI 0.501 to 0.606) and 0.508 for LDL-c (95% CI 0.450 to 0.566), with p = 0.2756. Conclusions: In a large real-world RACPAC cohort, neither elevated hsCRP nor LDL-c predicted the presence of coronary artery disease in the rapid access chest pain clinic (RACPAC) cohort. In contrast, CT coronary angiography (CTCA) demonstrated superior diagnostic accuracy compared with treadmill stress echocardiography (TSE) in this setting. Full article

Biventricular Takotsubo cardiomyopathy (TCM) is a rare variant characterized by involvement of both the left and right ventricles. This variant is associated with greater hemodynamic instability and longer hospital stays compared to the isolated left ventricular-only variant. We report the case of a 67-year-old female patient who underwent elective resection of a left adrenal adenoma. While her preoperative and intraoperative courses were uneventful, she developed cardiogenic shock postoperatively, necessitating prolonged intensive care unit (ICU) management and vasopressor support. Further evaluation revealed elevated high-sensitivity troponin levels and reduced ejection fraction on echocardiography (30–35%). Hypokinesis was noted in the apical and mid-ventricular segments of both ventricles. A coronary angiogram performed two months prior to admission showed no significant coronary artery disease. Based on these findings, a diagnosis of biventricular TCM was established. The patient was managed supportively and discharged in stable condition with ongoing therapy, including beta-blockers, renin–angiotensin–aldosterone system inhibitors (RAASis), and statins. Follow-up echocardiography showed resolution of regional wall motion abnormalities. Although rare, biventricular TCM is associated with increased severity and a higher risk of complications. Early recognition and timely management are essential to improve outcomes in affected patients. Full article

Background and Objectives: The conflicting findings in existing studies and insufficient evidence highlight the necessity for additional research on the relationship between sleep quality and coronary artery disease (CAD) in elderly acute coronary syndrome (ACS) patients. We aimed to investigate the association between sleep quality and the CAD severity of in geriatric patients with ACS. Materials and Methods: This retrospective observational cohort study analyzed data from 308 patients aged 65 years and older admitted with ACS who had undergone coronary angiography between May 2022 and June 2025 at a tertiary cardiology department. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) at the 6-month follow-up, with scores > 5 indicating poor quality. CAD severity was quantified by SYNTAX score from angiograms. The primary endpoint was the relationship between PSQI and SYNTAX score, with secondary analyses concerning factors associated with clinical outcomes. Results: Poor sleep quality (PSQI > 5) was associated with higher SYNTAX scores (p < 0.001), lower ejection fraction (p < 0.001), higher CRP (median 5.1 vs. 4.05, p = 0.029), NT-proBNP (median 748.5 vs. 595, p = 0.034), lower glomerular filtration rate (p = 0.025), and higher hypertension prevalence (p = 0.034). ST-elevation myocardial infarction was more common in subjects with poor sleep. Multivariable logistic regression identified hypertension (p = 0.011), reduced ejection fraction (p = 0.030), STEMI (p = 0.045), intermediate SYNTAX (p = 0.003), and high SYNTAX (p = 0.009) as associated factors of poor sleep. Conclusions: Poor sleep quality is independently linked to greater CAD severity in geriatric ACS patients. This is a modifiable risk factor that can reduce morbidity and mortality in this high-risk group. Full article

Background: While the 2024 ESC Guidelines provide guidance on utilising incidental CAC findings from non-gated CT scans to enhance risk stratification and guide treatment decisions, there remain gaps in detailed protocols for managing such incidental findings, particularly in inpatient settings. An incidental finding of CAC in a patient without known atherosclerosis provides an opportunity to assess cardiac risk, promote risk factor optimisation and evaluate need for further cardiac work up. The aim of this study was to assess the prevalence of incidental coronary artery calcification on non-cardiac dedicated gated CT thorax scans among general medical inpatients and to evaluate the subsequent management of these findings. Methods: This was a single-centre retrospective observational study of consecutive general medical inpatients aged 40–75, who had undergone a non-cardiac gated CT thorax during their admission, between February and March 2025. Data were collected using local electronic health records. Exclusion criteria were patients with known ischaemic heart disease (IHD). Risk factor assessment was noted by documentation of smoking status, hypertension, diabetes and low-density lipoprotein (LDL) values. Results: A total of 186 patients with thoracic CT scans were identified. On review of all CT reports, 53 (28.4%) patients had CAC reported, of whom 17 had known IHD. Therefore 36 (19.4%) patients were identified for further analysis. An exercise stress test was booked in none of the patients. A coronary angiogram was booked in 1 patient. Conclusions: One fifth of medical inpatients in our study had a new finding of CAC on thoracic imaging. Cardiovascular risk factors of LDL and HbA1c were checked in less than half of patients. None of these patients went on to have functional testing. There is a valuable opportunity to optimise cardiac risk factors and evaluate the need for functional testing in a subset of patients with CAC reported on non-cardiac CTs. This can be facilitated by raising awareness and implementing a flowchart tool for hospital physicians to reference. Full article

Background: Coronary disease (CAD) is a multifactorial complex pathology characterized by excessive inflammatory activation and oxidative stress. Amino acids are among the potential biomarkers for cardiovascular pathology. The analysis aimed to investigate the possible relationship between proteomic profiling and coronary artery disease risk as novel markers of CAD. Methods: Patients with similar demographic and clinical profiles, including the prevalence of comorbidities such as arterial hypertension, dyslipidemia, and diabetes mellitus, were divided into two groups based on the results of their coronary angiograms. Serum amino acid levels were measured using liquid chromatography–tandem mass spectrometry. Results: Patients with significant coronary atherosclerosis confirmed in coronary angiograms were characterized by higher levels of circulating cystine, threonine, methionine, and proline. The number of involved coronary arteries in atherosclerotic processes revealed a correlation with circulating levels of threonine, methionine, and proline, not cystine. The multivariable logistic regression analysis for any significant coronary artery disease prediction revealed higher values of circulating threonine as a possible risk factor. Thereafter, a subanalysis was conducted to examine the relationship between amino acid levels and atherosclerotic risk in specific coronary arteries. The multivariate analysis revealed cystine and proline as potential risk factors for atherosclerosis of the left descending artery (LAD). Higher values of threonine were identified as a possible risk factor for atherosclerotic plaque location in the circumflex artery in multivariate regression analysis. Proline circulating levels were found to be prognostic for right coronary artery disease. Conclusions: Elevated circulating levels of amino acids, including cystine, threonine, methionine, and proline, were observed in patients with significant coronary artery disease in our exploratory pilot study. The high circulating amino acid levels can be predictive of coronary artery disease in our multivariate models. Full article

Background/Objectives: Traditionally, women have been observed to have older age, more co-morbidities, and poorer long-term clinical outcomes following acute myocardial infarction (AMI) when compared to men. However, age-adjusted analyses have demonstrated that gender differences are often attenuated, and the potential influence of left ventricular function and structure have been infrequently studied. The aim of the present study was to evaluate how LV function could influence gender differences in the long-term incidence of a composite of clinically relevant cardiovascular outcomes. Methods: Patients treated with early PCI for AMI were examined with echocardiography 2–4 days after the index AMI and followed by a mean 73 (±13) months. The primary endpoint was the incidence of a composite of total death, recurrent myocardial infarction, hospitalization for angina pectoris with an angiogram documenting progression of coronary artery stenoses, new heart failure, evidence of stroke/transient ischemic attack (TIA), and ventricular arrhythmia. Results: Among the 236 patients studied, 179 (76%) were men, with an average age of 66 (±11) years, and 57 were women (24%), with an age of 65 (±10) years. Men exhibited a higher incidence of anterior STEMI (p = 0.030), lower left ventricular ejection fraction (LVEF) (p = 0.02), reduced global longitudinal strain (p = 0.001), and larger left ventricular end-systolic volume index (LVESVI) (p = 0.007) compared to women. Both genders had similar peak troponin T values and symptom-to-needle times, as well as an equivalent number of stents implanted, prevalence of co-morbidities, and discharge medication. After sixyears of follow-up, Kaplan–Meier curves revealed better long-term cardiovascular outcome-free survival among women (log-rank p = 0.041). Cox regression analysis indicated that neither age nor LVEF influenced this gender difference, which, however, was reduced and became non-significant when LVESVI was added (HR 1.747 (95% CI 0.89–3.43)). No difference in mortality was observed, but men had significantly higher rates of heart failure (p = 0.03). Conclusions: This study demonstrated that men with a previous PCI-treated AMI had a two-fold (HR 2.155) higher risk of a composite long-term cardiovascular outcome as compared with women. The detrimental effect of male gender remained significant after adjustments for age and LVEF, but the male gender effect was reduced and became insignificant after adjustment for age and LVESVI. In view of this, our findings indicate that higher LVESVI may partly explain the detrimental effect of male gender on cardiovascular outcomes after PCI-treated AMI. Full article

Background: The STEMI/NSTEMI classification guides management and quality metrics for acute myocardial infarction (AMI). We examined whether the final cath-lab diagnosis of STEMI versus NSTEMI correlates more closely with door-to-balloon (D2B) time than with either ST-segment elevation (STE) on pre-angiogram ECG or a culprit lesion with TIMI 0-1 flow. Methods: This retrospective study analyzed 410 patients with AMI from the DOMI-ARIGATO database who underwent coronary angiography. For each patient, we recorded FDx coded by the interventional cardiologist, D2B < 120 min versus > 120 min, STE criteria (Fourth Universal Definition), and angiographic TIMI 0-1 culprit. Predictors of FDx-STE discordance were evaluated with multivariable logistic regression. Results: Among 410 angiographed AMI patients (mean age 63 ± 13; 71% male), 165 (40.2%) received an FDx-STEMI and 245 (59.8%) an FDx-NSTEMI. D2B time showed 94% agreement with FDx (160/165 FDx-STEMI treated < 120 min; 225/245 FDx-NSTEMI treated > 120 min), exceeding concordance for STE (82%; p < 0.001) and TIMI 0-1 flow (75%; p < 0.001). FDx and STE diverged in 75 patients (18%): 60 rapidly treated STE-negative cases were labelled STEMI, whereas 15 delayed STE-positive cases were labelled NSTEMI. In regression analysis, D2B < 120 min remained the sole independent predictor of discordance (adjusted OR 6.7, 95% CI 3.5–13.8). Conclusions: In this registry, the cath-lab label “STEMI” showed the strongest correlation with meeting a 120 min benchmark, exceeding correlations for STE or angiographic occlusion. These findings suggest that quality-metric compliance, rather than electrocardiographic or anatomic criteria, predominantly drives final diagnosis. Full article

The proportion of laboratory tests ordered in cardiology departments without clinical utility is unclear. The objective of this study was to determine if criteria limiting testing can safely reduce admission and follow-up testing. We reviewed the charts of 471 consecutive patients admitted to the cardiology department at a regional hospital from January 2019 to June 2019. We prospectively set appropriate criteria for routine admission and follow-up testing. Commonly ordered tests and parameters considered not to be indicated either on admission or on follow-up included C-reactive protein, liver function tests, lactate dehydrogenase, creatine phosphokinase, calcium, blood urea nitrogen, uric acid, cholesterol, Hemoglobin A1c, and prothrombin times (except for patients treated with warfarin). Admission tests considered appropriate included electrolytes, glucose, creatinine, and complete blood counts. Follow-up testing was indicated only if test results were outside the reference ranges. Troponin tests were only indicated if needed to determine the need for a coronary angiogram. The outcome variables were the proportion of indicated tests and whether tests outside the criteria led to changes in acute care that positively affected the patient’s hospital care. In the 471 patients, there were 18,061 tests ordered (not including troponin), and 14,427 (79.9%) were not indicated; this led to 46 (0.3%) changes in medical care, which did not affect the patients’ clinical course. There were 47.8% (364/761) troponin tests that were not indicated and did not change patient care. Our study suggests that interventions in cardiology departments such as ours could safely reduce troponin testing by nearly 50% and other laboratory tests by around 80%. These results need to be confirmed in other settings and in interventional studies. Full article

Chronic total occlusions (CTOs), defined as complete coronary artery blockages persisting for over three months, are frequently encountered in up to 25% of coronary angiograms. Although percutaneous coronary intervention (PCI) for CTO remains technically challenging, advancements in guidewires, microcatheters, re-entry devices, and intravascular imaging, along with the expertise of specialized operators, have significantly improved procedural success rates, now exceeding 90% in expert centers. While recent evidence, such as the SYNTAX II study, emphasizes the importance of complete revascularization, over half of CTO cases continue to be managed conservatively with optimal medical therapy (OMT), partly due to the limited high-quality randomized evidence supporting revascularization. Observational studies have demonstrated that successful CTO-PCI is associated with improved angina relief, quality of life, left ventricular function, and possibly long-term survival. Extended observational follow-up, such as the Korean and Canadian registries, suggests long-term reductions in cardiac and all-cause mortality with CTO revascularization. However, randomized controlled trials (RCTs) have primarily shown symptomatic benefit, with no consistent reduction in major adverse cardiac events (MACE) or mortality, likely due to limited sample sizes, short follow-up, and treatment crossovers. Various strategies, including the hybrid algorithm, guide CTO interventions by balancing antegrade and retrograde techniques based on lesion complexity. Imaging modalities such as coronary CT angiography and intravascular ultrasound play a pivotal role in planning and optimizing these procedures. Future innovations, such as real-time fusion imaging of CCTA with coronary angiography, may enhance lesion visualization and guidewire navigation. While current guidelines recommend CTO-PCI in selected symptomatic patients with demonstrable ischemia or viable myocardium, the decision should be individualized, incorporating anatomical feasibility, comorbidities, patient preferences, and input from a multidisciplinary Heart Team. Looking ahead, adequately powered RCTs with extended follow-up are essential to determine the long-term clinical impact of CTO-PCI on hard outcomes such as mortality and myocardial infarction. Full article

Coronary artery disease (CAD) is one of the leading causes of mortality worldwide, highlighting the importance of developing accurate and efficient diagnostic tools. This study presents a comparative evaluation of three recent YOLO architecture versions (YOLOv8, YOLOv9, and YOLOv11) for the tasks of coronary vessel segmentation and stenosis detection using the ARCADE dataset. Two workflows were explored: one with original angiographic images and another incorporating Contrast Limited Adaptive Histogram Equalization (CLAHE) for image enhancement. Models were trained for 100 epochs using the AdamW optimizer and evaluated with precision, recall, and F1-score under a pixel-based segmentation framework. YOLOv9-E achieved the highest performance in vessel segmentation with an F1-score of 0.4524, while YOLOv11-X was most effective for stenosis detection, achieving an F1-score of 0.7826. Although CLAHE improved local contrast, it did not consistently improve segmentation results and occasionally introduced artifacts that negatively affected model performance. Compared to state-of-the-art methods, the YOLO models demonstrated competitive results, especially for large, well-defined coronary segments, but showed limitations in detecting smaller or more complex pathological structures. These findings support the use of YOLO-based architectures for real-time CAD segmentation tasks and highlight opportunities for future improvement through the integration of attention mechanisms or hybrid deep learning strategies. Full article

Background and Objectives: Up to 40% of patients undergoing a coronary angiogram due to angina pectoris have no obstructive coronary artery disease, also known as angina with non-obstructive coronary arteries (ANOCA). ANOCA is associated with significant impairment in patients’ quality of life, increased risk of myocardial infarction and all-cause mortality. Approximately 25% of patients with ANOCA have persisting symptoms despite optimal medical therapy. There is a lack of in-depth knowledge regarding tailored treatment for patients with ANOCA due to a scarcity of trials designed to assess the effect of treatment modalities. The aim of this systematic review and meta-analysis is to give clinicians an overview of the efficacy of current treatment modalities for patients with ANOCA. Methods: PudMed/MEDLINE, Embase, the Cochrane Library and clinical trial registries were searched for randomised controlled and cohort studies regarding treatment modalities for ANOCA. The main outcome was change in angina pectoris frequency for each treatment modality. Secondary outcomes included changes in exercise capacity, quality of life, Canadian Cardiovascular Society (CCS) class, coronary flow reserve (CFR) and survival. Results: In total, 80 studies were included and used in the meta-analysis, of which ten studies met the current definition of ANOCA. Angina pectoris frequency improved significantly in the majority of the treatment modalities, with neuromodulation resulting in −3.35 standardised mean difference (SMD) (95% CI: −5.13; −1.56), trimetazidine in −1.74 SMD (−2.63; −0.85), traditional Chinese medicine in −1.55 SMD (−2.36; −0.75), beta-blockers in −1.32 SMD (−1.88; −0.77), enhanced external counterpulsation in −1.27 SMD (−2.04; −0.49), stem cell therapy in −1.04 SMD (−1.51; −0.57), lifestyle interventions in −0.86 SMD (−1.15; −0.57), RAAS-inhibitors in −0.83 SMD (−1.31; −0.35) and calcium channel blockers in −0.64 SMD (−0.92; −0.35). Conclusions: This meta-analysis into treatment modalities for patients with ANOCA shows a significant improvement in angina pectoris frequency in the majority of included treatment modalities. However, these results should be interpreted cautiously, as only ten of the studies included in the meta-analysis meet the current definition of ANOCA. This review underlines the importance of undertaking new studies with existing treatment modalities to determine the efficacy in patients with ANOCA. Full article

Background/Objectives: The automatic identification of coronary artery dominance holds critical importance for clinical decision-making in cardiovascular medicine, influencing diagnosis, treatment planning, and risk stratification. Traditional classification methods rely on the manual visual interpretation of coronary angiograms. However, current deep learning approaches typically classify right and left coronary artery angiograms separately. This study aims to develop and evaluate an integrated video-based deep learning framework for classifying coronary dominance without distinguishing between RCA and LCA angiograms. Methods: Three advanced video-based deep learning models—Temporal Segment Networks (TSNs), Video Swin Transformer (VST), and VideoMAEv2—were implemented using the MMAction2 framework. These models were trained and evaluated on a large dataset derived from a publicly available source. The integrated approach processes entire angiographic video sequences, eliminating the need for separate RCA and LCA identification during preprocessing. Results: The proposed framework demonstrated strong performance in classifying coronary dominance. The best test accuracies achieved using TSNs, Video Swin Transformer, and VideoMAEv2 were 87.86%, 92.12%, and 92.89%, respectively. Transformer-based models showed superior accuracy compared to convolution-based methods, highlighting their effectiveness in capturing spatial–temporal patterns in angiographic videos. Conclusions: This study introduces a unified video-based deep learning approach for coronary dominance classification, eliminating manual arterial branch separation and reducing preprocessing complexity. The results indicate that transformer-based models, particularly VideoMAEv2, offer highly accurate and clinically feasible solutions, contributing to the development of objective and automated diagnostic tools in cardiovascular imaging. Full article

Background/Objectives: The role of speckle-tracking echocardiography in the diagnosis of stable coronary artery disease (CAD) remains controversial. The aim of this study was to assess the diagnostic accuracy of global longitudinal strain (GLS) in predicting significant CAD. Methods: In this prospective study, 103 symptomatic patients referred for invasive coronary angiography were enrolled. All patients underwent resting echocardiography with GLS assessment prior to angiography. Exclusion criteria included acute coronary syndrome, known history of CAD, and the presence of left ventricular wall motion abnormalities. Significant CAD was defined as ≥50% stenosis in at least one major epicardial coronary artery. Results: The mean patient age was 63.8 ± 9.3 years, with 78.6% being male. Hypertension was present in 63.1% of patients, dyslipidemia in 77.7%, diabetes mellitus in 22.3%, smoking history in 71.9%, and a family history of premature CAD in 24.3%. Significant CAD was identified in 45.6% (n = 47), while the remaining 54.3% (n = 56) had non-significant or no coronary artery disease. Patients with significant CAD exhibited significantly lower GLS values compared to those without (−15.73 ± 2.64% vs. −17.6 ± 1.85%, p = 0.001). A GLS threshold of >−16.3 predicted significant CAD with 66% sensitivity and 73.2% specificity (AUC = 0.692, p = 0.001). GLS demonstrated diagnostic accuracy in identifying disease in individual coronary territories, with AUCs of 0.754 for the left anterior descending artery (LAD), 0.714 for the left circumflex artery (LCx), and 0.723 for the right coronary artery (RCA). Diagnostic performance improved when GLS was combined across all three territories (AUC = 0.796). Conclusions: Resting myocardial GLS is accurate in detecting ischemic myocardial dysfunction and can accurately predict significant stenosis of the respective coronary branch subtending the segments. Full article